When.com Web Search

  1. Ads

    related to: sickle cell disease genes
    • Find an ATC

      Find an Authorized Treatment Center

      On the Official Patient Website.

    • Patient Information

      View Important Patient Information.

      Understand the Treatment.

Search results

  1. Results From The WOW.Com Content Network
  2. What Is Priapism & How Can Men Treat It? - AOL

    www.aol.com/priapism-men-treat-105700788.html

    Priapism commonly occurs in men with sickle cell disease, and the risk increases with age. ... As you can see, some of these are within your control, while others are related to genetics or illness.

  3. CRISPR gene editing - Wikipedia

    en.wikipedia.org/wiki/CRISPR_gene_editing

    In 2023, the first drug making use of CRISPR gene editing, Casgevy, was approved for use in the United Kingdom to cure sickle-cell disease and beta thalassemia. [13] [14] Casgevy was approved for use in the United States on December 8, 2023, by the Food and Drug Administration. [15]

  4. Down 21% This Year, Is CRISPR Therapeutics Stock Still a Buy?

    www.aol.com/finance/down-21-crispr-therapeutics...

    It treats sickle cell disease (SCD) and beta thalassemia, both rare inherited illnesses that affect the function of a person's red blood cells. ... One of those programs is a clinical-stage gene ...

  5. Fragile X syndrome - Wikipedia

    en.wikipedia.org/wiki/Fragile_X_syndrome

    Fragile X syndrome (FXS) is a genetic neurodevelopmental disorder characterized by mild-to-moderate intellectual disability. [1] The average IQ in males with FXS is under 55, while about two thirds of affected females are intellectually disabled. [3][4] Physical features may include a long and narrow face, large ears, flexible fingers, and ...

  6. Genetics - Wikipedia

    en.wikipedia.org/wiki/Genetics

    For example, sickle-cell anemia is a human genetic disease that results from a single base difference within the coding region for the β-globin section of hemoglobin, causing a single amino acid change that changes hemoglobin's physical properties. [78]

  7. The Best Biotech Stock to Invest $1,000 in Right Now - AOL

    www.aol.com/finance/best-biotech-stock-invest-1...

    Inaxaplin is already in a phase 3 trial for treating APOL1-mediated kidney disease. This indication would open up an even bigger market than CF to Vertex if the experimental drug wins approval.

  1. Ads

    related to: sickle cell disease genes